BR112023000233A2 - STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS - Google Patents

STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS

Info

Publication number
BR112023000233A2
BR112023000233A2 BR112023000233A BR112023000233A BR112023000233A2 BR 112023000233 A2 BR112023000233 A2 BR 112023000233A2 BR 112023000233 A BR112023000233 A BR 112023000233A BR 112023000233 A BR112023000233 A BR 112023000233A BR 112023000233 A2 BR112023000233 A2 BR 112023000233A2
Authority
BR
Brazil
Prior art keywords
lacticaseibacillus
compositions
treatment
infections
genitoourinary
Prior art date
Application number
BR112023000233A
Other languages
Portuguese (pt)
Inventor
Secondini Lorenzo
Lucia Randazzo Cinzia
Cianci Antonio
Cianci Stefano
Caggia Cinzia
Pino Alessandra
Catera Mietta
Original Assignee
Uriach Italy S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach Italy S R L filed Critical Uriach Italy S R L
Publication of BR112023000233A2 publication Critical patent/BR112023000233A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

CEPA DA ESPÉCIE LACTICASEIBACILLUS RHAMNOSUS, COMPOSIÇÕES DA MESMA E USO DA MESMA NO TRATAMENTO DE INFECÇÕES GENITOURINÁRIAS. A presente invenção refere-se a uma cepa bacteriana isolada e caracterizada pertencente à espécie Lacticaseibacillus rhamnosus, às composições da mesma e ao uso da mesma no tratamento de infecções e/ou inflamações genitourinárias.STRAIN OF THE LACTICASEIBACILLUS RHAMNOSUS SPECIES, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS. The present invention refers to an isolated and characterized bacterial strain belonging to the Lacticaseibacillus rhamnosus species, its compositions and its use in the treatment of genitourinary infections and/or inflammations.

BR112023000233A 2020-07-09 2021-07-09 STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS BR112023000233A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000016666A IT202000016666A1 (en) 2020-07-09 2020-07-09 NEW STRAIN OF THE LACTICASEIBACILLUS RHAMNOSUS SPECIES, ITS COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GENITOURINARY INFECTIONS
PCT/IB2021/056187 WO2022009170A1 (en) 2020-07-09 2021-07-09 Novel strain of the species lacticaseibadllus rhamnosus, compositions thereof and use thereof in the treatment of genitourinary infections

Publications (1)

Publication Number Publication Date
BR112023000233A2 true BR112023000233A2 (en) 2023-03-14

Family

ID=72801836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023000233A BR112023000233A2 (en) 2020-07-09 2021-07-09 STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS

Country Status (7)

Country Link
US (1) US20230270797A1 (en)
EP (1) EP4178599A1 (en)
CN (1) CN116033914A (en)
AU (1) AU2021304480A1 (en)
BR (1) BR112023000233A2 (en)
IT (1) IT202000016666A1 (en)
WO (1) WO2022009170A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024028764A1 (en) * 2022-08-03 2024-02-08 Probioetna S.R.L. Lacticaseibacillus rhamnosus dsm 33960 and its use in a method for the prevention and treatment of urogenital tract dysbiosis
CN116200306B (en) * 2023-02-13 2023-12-19 微康益生菌(苏州)股份有限公司 Lactobacillus rhamnosus LRa16, and application and product thereof in preparation of medicines for treating genital tract infection
CN117384797B (en) * 2023-11-14 2024-04-05 完美（广东）日用品有限公司 Rhamnose cheese bacillus LRPerfectus158 and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2428214A1 (en) * 2010-09-14 2012-03-14 HSO Health Care GmbH Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Also Published As

Publication number Publication date
EP4178599A1 (en) 2023-05-17
IT202000016666A1 (en) 2022-01-09
US20230270797A1 (en) 2023-08-31
AU2021304480A1 (en) 2023-02-09
WO2022009170A1 (en) 2022-01-13
CN116033914A (en) 2023-04-28

Similar Documents

Publication Publication Date Title
BR112023000233A2 (en) STRAIN OF THE SPECIES LACTICASEIBACILLUS RHAMNOSUS, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OF GENITOOURINARY INFECTIONS
WO2018229236A3 (en) Compositions comprising bacterial strains
BR112018077266A2 (en) compositions comprising bacterial strains
CO2017012829A2 (en) Compositions comprising bacterial strains
BRPI0616960B8 (en) use of lactobacillus for the treatment of viral infections
BR112018015535B8 (en) MIXTURE, COMPOSITION, PLANT PROPAGATION MATERIAL, USE OF A MIXTURE AND CONTROL METHOD, SUPPRESSION OF PATHOGENS ON PLANTS OR PREVENTION OF INFECTION OF PLANTS BY PATHOGENS
EP4375382A3 (en) Bacterial strains having fungicidal activity, compositions comprising same and use thereof
MX2020010076A (en) Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof.
BR112018014654A2 (en) innovative strain of probiotic bacteria and compositions and uses thereof
BR112018003123A2 (en) composition, enema, isolated strain, method for treating and / or preventing a gastrointestinal condition, and use of an isolated bacterial composition, enema or one or more isolated strains
BR112018016359A2 (en) Biopesticides for potato blight disease
WO2020085698A3 (en) Antimicrobial peptide derived from defense protein of octopus minor or fragment thereof, and antimicrobial composition comprising same
WO2018158306A8 (en) Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
WO2017199022A3 (en) Lactobacillus rhamnosus lysate compositions and uses thereof
BR112022003209A2 (en) Inhibition methods with microbial strains and antibiotics
MX2021015961A (en) Novel molecules.
WO2018176093A8 (en) Berberine alkaloid formulations in the prevention and/or treatment of infectious disease
CO2023016983A2 (en) Bacterial strains that have fungicidal activity, compositions that comprise them and use of these
BR112022005345A2 (en) IMMUNOGENIC COMPOSITIONS
BR112021025362A2 (en) serpin production
WO2018140707A8 (en) Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces
BR112019002023A2 (en) prevention or treatment of antifungal infections vectorized by probiotic bacteria
BR112022024911A2 (en) MATERIALS AND METHODS FOR INHIBITING A VIRAL INFECTION, INCLUDING A CORONA VIRUS INFECTION
EP4233912A3 (en) Compositions for use as a prophylactic agent to those at risk of infection of tuberculosis, or as secondary agents for treating infected tuberculosis patients
MX2021013833A (en) Methods and compositions comprising staphylococcus protein a (spa) variants.